DDInter758 DDInter381
Fluoxetine is a 2nd generation antidepressant categorized as a selective serotonin reuptake inhibitor (SSRI). It gained FDA approval in 1987 and although it was initially intended for the treatment of depression, today it is commonly prescribed to manage depression in addition to various other pathologies.
Cinacalcet is a calcimimetic sold by Amgen under the trade name Sensipar® in North America and Australia and as Mimpara® in Europe. It is used to treat hyperparathyroidism due to parathyroid tumours or renal failure.
Fluoxetine {u} (Compound) resembles {v} (Compound) Cinacalcet
Fluoxetine {u} (Compound) resembles {v} (Compound) Etofenamate
Etofenamate {u} (Compound) resembles {v} (Compound) Cinacalcet
Fluoxetine {u} (Compound) resembles {v} (Compound) Duloxetine
Duloxetine {u} (Compound) resembles {v} (Compound) Cinacalcet
Fluoxetine {u} may lead to a major life threatening interaction when taken with {v} Dexfenfluramine
Dexfenfluramine {u} (Compound) resembles {v} (Compound) Cinacalcet
Fluoxetine {u} (Compound) binds {v} (Gene) CYP1A2
CYP1A2 {u} (Gene) is bound by {v} (Compound) Cinacalcet
Fluoxetine {u} (Compound) causes {v} (Side Effect) Dyspepsia
Dyspepsia {u} (Side Effect) is caused by {v} (Compound) Cinacalcet
Fluoxetine {u} (Compound) resembles {v} (Compound) Etofenamate
Etofenamate {u} (Compound) resembles {v} (Compound) Floctafenine
Floctafenine {u} (Compound) resembles {v} (Compound) Cinacalcet
Fluoxetine {u} (Compound) resembles {v} (Compound) Duloxetine
Duloxetine {u} (Compound) resembles {v} (Compound) Propranolol
Propranolol {u} (Compound) resembles {v} (Compound) Cinacalcet
Fluoxetine {u} may lead to a major life threatening interaction when taken with {v} Dexfenfluramine
Dexfenfluramine {u} may lead to a major life threatening interaction when taken with {v} Duloxetine
Duloxetine {u} (Compound) resembles {v} (Compound) Cinacalcet
Fluoxetine {u} (Compound) binds {v} (Gene) CYP1A2
CYP1A2 {u} (Gene) is bound by {v} (Compound) Propranolol
Propranolol {u} (Compound) resembles {v} (Compound) Cinacalcet
Fluoxetine (Compound) resembles Cinacalcet (Compound)
Fluoxetine (Compound) resembles Etofenamate (Compound) and Etofenamate (Compound) resembles Cinacalcet (Compound)
Fluoxetine (Compound) resembles Duloxetine (Compound) and Duloxetine (Compound) resembles Cinacalcet (Compound)
Fluoxetine may lead to a major life threatening interaction when taken with Dexfenfluramine and Dexfenfluramine (Compound) resembles Cinacalcet (Compound)
Fluoxetine (Compound) binds CYP1A2 (Gene) and CYP1A2 (Gene) is bound by Cinacalcet (Compound)
Fluoxetine (Compound) causes Dyspepsia (Side Effect) and Dyspepsia (Side Effect) is caused by Cinacalcet (Compound)
Fluoxetine (Compound) resembles Etofenamate (Compound) and Etofenamate (Compound) resembles Floctafenine (Compound) and Floctafenine (Compound) resembles Cinacalcet (Compound)
Fluoxetine (Compound) resembles Duloxetine (Compound) and Duloxetine (Compound) resembles Propranolol (Compound) and Propranolol (Compound) resembles Cinacalcet (Compound)
Fluoxetine may lead to a major life threatening interaction when taken with Dexfenfluramine and Dexfenfluramine may lead to a major life threatening interaction when taken with Duloxetine and Duloxetine (Compound) resembles Cinacalcet (Compound)
Fluoxetine (Compound) binds CYP1A2 (Gene) and CYP1A2 (Gene) is bound by Propranolol (Compound) and Propranolol (Compound) resembles Cinacalcet (Compound)